Fact Sheet: The 340B Drug Pricing Program - AHA Section 340B of the Public Health Service Act requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to health care organizations that care for many uninsured and low-income patients
340B Drug Pricing Program - Wikipedia The 340B Drug Pricing Program is a US federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices
340B Drug Pricing Program | HRSA HHS is reconsidering whether to implement a 340B Rebate Model Pilot Program consistent with its statutory authority HRSA issued a Request for Information (RFI) to gather input from interested parties regarding the potential use of rebates to effectuate the ceiling price under the 340B Program
Detailed Overview - 340B Health Section 340B requires pharmaceutical manufacturers to enter into an agreement, called a pharmaceutical pricing agreement (PPA), with the HHS Secretary in exchange for having their drugs covered by Medicaid and Medicare Part B
340B Report - 340B Report is the indispensable source of independent . . . In-House Data Requirements Tracker State Contract Pharmacy Bills Laws State Provider Reporting Bills Laws State PBM Reimbursement Laws Drugmaker State Exemptions Tracker Congressional 340B Bill Tracker State Litigation Tracker 340B Leaders Industry Insights Spotlights Our Sponsors 340B Industry Leaders 340B Solutions Spotlight
340B Program - Henry Schein 340B Medical What Is the 340B Program? The 340B Drug Pricing Program was created in 1992, and it is codified as Section 340B of the Public Health Services Act
About 340B With broad bipartisan support, President George H W Bush signed Section 340B of the Public Health Service Act into law to support our nation’s safety-net providers – the health centers, hospitals, clinics and programs that never turn anyone away from their care
340B Program: Major Developments Through Early 2026 See the latest policy updates that affect 340B covered entities, including news on the rebate model, OPPS drug cost survey, and federal and state legislation
Sea Ray 340 Sundancer boats for sale - Boat Trader Find 181 Sea Ray 340 Sundancer boats for sale near you, including boat prices, photos, and more Locate Sea Ray boat dealers and find your boat at Boat Trader!
State Legislative Actions and the Federal 340B Drug Pricing Program 340B program growth: Spending by covered entities on 340B drug purchases rose from $ 66 billion in 2023 to $81 billion in 2024 Drivers of growth include increased prices, use of high-cost specialty drugs and the expansion in contract pharmacy participation